Green tea and pancreatic cancer chemoprevention

Green Tea: Varieties, Production and Health Benefits

Volumn , Issue , 2013, Pages 75-90

  Vuong, Quan V ^a   Scarlett, Christopher J ^a,b   Roach, Paul D ^a  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892932206     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (64)

1. Wan, X.; Li, D.; Zhang, Z., Green tea and black tea manufacturing and consumption. In Tea and tea products: Chemistry and health-Promoting properties, Ho, C. T.; Lin, J. K.; Shahidi, F., Eds. Taylor and Francis Group: Boca Raton, 2009; pp 255-274.
2. Vuong, Q. V.; Golding, J. B.; Nguyen, M.; Roach, P. D., Extraction and isolation of catechins from tea. Separation Science 2010, 33, 3415-3428.
3. Cheng, T. O., All teas are not created equal: The Chinese green tea and cardivascular health. International Journal of Cardiology 2006, 108, 301-308.
4. Vuong, Q. V., Epidemiological evidence linking tea consumption to human health: A review. Critical Reviews in Food Science and Nutrition 2012, 52. DOI: 10.1080/10408398.2011.594184.
5. Graham, H. N., Green tea composition, consumption, and polyphenol chemistry. Preventive Medicine 1992, 21, 334-350.
6. Vuong, Q. V.; Stathopoulos, C. E.; Nguyen, M. H.; Golding, J. B.; Roach, P. D., Isolation of green tea catechins and their utilisation in the food industry. Food Reviews International 2011, 27, 227-247.
7. Mukhtar, H.; Ahmad, N., Tea polyphenols: prevention of cancer and optimizing health. The American Journal of Clinical Nutrition 2000, 71, 1698S-1702S.
8. Su, X.; Duan, J.; Jiang, Y.; Shi, J.; Kakuda, Y., Effects of soaking conditions on the antioxidant potentials of oolong tea. Journal of Food Composition and Analysis 2006, 19, 348-353.
9. Balentine, D. A.; Harbowy, M. E.; Graham, H. N., Tea: The plant and its manufacture; chemistry and consumption of the beverage. In Caffeine, Spiller, G. A., Ed. CRC Press: Boca Raton, 1998; pp 37-68.
10. Chu, D. C.; Juneja, L. R., General chemical composition of green tea and its infusion. In Chemistry and applications of green tea, Yamamoto, T., Juneja, L. R., Chu, D. C., and Kim, M., Ed. CRC Press: Boca Raton, 1997; pp 13-22.
11. Kato, M.; Shibamoto, T., Variation of Major Volatile Constituents in Various Green Teas from Southeast Asia. Journal of Agriculture and Food Chemistry 2009, 49, 1394-1396.
12. Greenwald, P., Cancer chemoprevention. British Medical Journal 2002, 324, 714-718.
13. Tsao, S. A.; Kim, E. S.; Hong, W. K., Chemoprevention of Cancer. A Cancer Journal for Clinicians 2004, 54, 150-180.
14. Hara, Y., Green tea: Health benefits and applications. Marcel Dekker: New York, 2001.
15. Khan, N.; Mukhtar, H., Tea polyphenols for health promotion. Life Sciences 2007, 81, 519-533.
16. Sharangi, A. B., Medicinal and therapeutic potentialities of tea (Camellia sinensis L.) -A review. Food research international 2009, 42, 529-535.
17. Liu, Q.; Duan, H.; Luan, J.; Yagasaki, K.; Zhang, G., Effects of theanine on growth of human lung cancer and leukemia cells as well as migration and invasion of human lung cancer cells. Cytotechnology 2009, 59, 211-217.
18. Friedman, M.; Mackey, B. E.; Kim, H. J.; Lee, I. S.; Lee, K. R.; Lee, S. U.; Kozukue, E.; Kozukue, N., Structure-activity relationships of tea compounds against human cancer cells. Journal of Agriculture and Food Chemistry 2007, 55, 243-253.
19. Sadzuka, Y.; Sugiyama, T.; Suzuki, T.; Sonobe, T., Enhancement of the activity of doxorubicin by inhibition of glutamate transporter. Toxicology Letters 2001, 123, 159-167.
20. Jemal, A.; Siegel, R.; Xu, J.; Ward, E., Cancer statistics, 2010. A Cancer Journal for Clinicians 2010, 60, 277-300.
21. Robertson, G. L., Food packaging: principles and practice. Marcel Dekker: New York 1993.
22. Vuong, Q. V.; Golding, J. B.; Stathopoulos, C. E.; Nguyen, M. H.; Roach, P. D., Optimizing conditions for the extraction of catechins from green tea using hot water. Journal of Separation Science 2011, 34, 3099-3106.
23. Ishizu, T.; Tsutsumi, H.; Sato, T., Interaction between gallocatechin gallate and caffeine in crystal structure of 1:2 and 2:2 complexes. Tetrahedron Letters 2009, 50, 4121-4124.
24. Zijp, I. M.; Korver, O.; Tijburg, L. B. M., Effect of tea and other dietary factors on iron absorption. Critical Reviews in Food Science and Nutrition 2000, 40, 371-398.
25. Zaveri, N. T., Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications. Life Sciences 2006, 78, 2073-2080.
26. Kao, Y. H.; Chang, H. H.; Lee, M. J.; Chen, C. L., Tea, obesity, and diabetes. Molecular Nutrition & Food Research 2006, 50, 188-210.
27. Klaus, S.; Pültz, S.; Thöne-Reineke, C.; Wolfram, S., Epigallocatechin gallate attenuates diet-induced obesity in mice by decreasing energy absorption and increasing fat oxidation. International Journal of Obesity 2005, 29, 615-623.
28. Vuong, Q. V.; Bowyer, M. C.; Roach, P. D., L-Theanine: properties, synthesis and isolation from tea. Journal of the Science of Food and Agriculture 2011, 91, 1931-1939.
29. Zhang, G.; Miura, Y.; Yagasaki, K., Inhibitory effectsof theanine andsera from theanine-fed rats on receptor-mediated cancer cell invasion beneath mesothelial-cell monolayers. Cytotechnology 2001, 36, 195-200.
30. Cooper, R.; Morré, D. J.; Morré, D., Medicinal Benefits of Green Tea: Part I. Review of Noncancer Health Benefits. Journal of Alternative and Complementary Medicine 2005, 11, 521-528.
31. Yokogoshi, H.; Kobayashi, M., Hypotensive effect of γ-glutamylmethylamide in spontaneously hypertensive rats. Life Sciences 1998, 62, 1065-1068.
32. Kurihara, S.; Shibahara, S.; Arisaka, H.; Akiyama, Y., Enhancement of antigen-specific immunoglobulin G production in mice by co-administration of L-cystine and Ltheanine. Journal of Veterinary Medical Science 2007, 69, 1263-1270.
33. Zheng, G.; Sayama, K.; Okubo, T.; Juneja, L. R.; Oguni, L., Anti-obesity effects of three major components of green tea, catechins, caffeine and theanine, in mice. in vivo2004, 18, 55-62.
34. Glade, M. J., Caffeine-Not just a stimulant. Nutrition 2010, 26, 932-938.
35. Griffiths, R. R.; Woodson, P. P., Caffeine physical dependence: a review of human and laboratory animal studies. Psychopharmacology 1998, 94, 437-451.
36. Harbowy, M. E.; Balentine, D. A., Tea chemistry. Critical Reviews in Plant Sciences 1997, 16, 415-480.
37. Jiang, H. Y., White tea, its manufacture, chemistry, and health effects. In Tea and tea products, chemistry and health-promoting properties, Ho, C. T.; Lin, J. K.; Shahidi, F., Eds. CRC Press: Boca Roton, 2009; pp 17-29.
38. Hursting, S. D.; Slaga, T. J.; Fischer, S. M.; DiGiovanni, J.; Phang, J. M., Mechanism-based cancer prevention approaches: Targets, examples, and the use of transgenic mice. Journal of the National Cancer Institute 1999, 91, 215-225.
39. Singh, B. N.; Shankar, S.; Srivastava, R. K., Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemical Pharmacology 2011, 82, 1807-1821.
40. Lin, J. K., Mechanisms of cancer chemoprevention by tea and tea polyphenols. In Tea and tea products: Chemistry and health-promoting properties, Ho, C. T.; Lin, J. K.; Shahidi, F., Eds. CRC Press: Boca Raton, 2009; pp 161-176.
41. Lin, J.K.; Chen, P.C.; Ho, C.T.; Lin-Shiau, S.Y., Inhibition of xanthine oxidase and suppression of intracellular reactive oxygen species in HL-60 cells by theaflavin-3,3'-digallate, (-)-epigallocatechin-3-gallate, and propyl gallate. Journal of Agriculture and Food Chemistry 2000, 48, 2736-2743.
42. Liang, Y. C.; Lin-shiau, S. Y.; Chen, C. F.; Lin, J. K., Suppression of extracellular signals and cell proliferation through EGF receptor binding by (-)-epigallocatechin gallate in human A431 epidermoid carcinoma cells. Journal of Cellular Biochemistry 1997, 67, 55-65.
43. Garbisa, S.; Sartor, L.; Biggin, S.; Salvato, B.; Benelli, R.; Albini, A., Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate. Cancer 2001, 91, 822-832.
44. Zhang, G.; Miura, Y.; Yagasaki, K., Effects of dietary powdered green tea and theanine on tumor growth and endogenous hyperlipidemia in hepatoma-bearing rats. Bioscience, Biotechnology and Biochemistry 2002, 66, 711-716.
45. Zhang, G.; Miura, Y.; Yagasaki, K., Inhibitory effects of theanine and sera from theanine-fed rats on receptor-mediated cancer cell invasion beneath mesothelial-cell monolayers. Cytotechnology 2001, 36, 195-200.
46. Sugiyama, T.; Sadzuka, Y., Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma. Cancer Letters 1998, 13, 19-26.
47. Sadzuka, Y.; Sugiyama, T.; Sonobe, T., Improvement of idarubicin induced antitumor activity and bone marrow suppression by theanine, a component of tea. Cancer Letters 2000, 158, 119-124.
48. Sugiyama, T.; Sadzuka, Y.; Nagasawa, K.; Ohnishi, N.; Yokoyama, T.; Sonobe, T., Membrane transport and antitumor activity of pirarubicin, and comparison with those of doxorubicin. Japanese Journal of Cancer Research 1999, 90, 775-780.
49. Stan, S. D.; Singh, S. V.; Brand, R. E., Chemoprevention strategies for pancreatic cancer. Nature Reviews Gastroenterology and Hepatology 2010, 7, 347-356.
50. O'Sullivan, A.; Kocher, H. M., Pancreatic cancer. Br. Med. J. Clin Evid. 2007, 11, 409-437.
51. Bardeesy, N.; DePinho, R. A., Pancreatic cancer biology and genetics. Nature Reviews Cancer 2002, 2, 897-909.
52. Friedlander, S. Y. G.; Chu, G. C.; Snyder, E. L.; Girnius, N.; Dibelius, G.; Crowley, D.; Vasile, E.; DePinho, R. A.; Jacks, T., Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras. Cancer Cell 2009, 16, 379-389.
53. Scarlett, C. J.; Salisbury, E. L.; Biankin, A. V.; Kench, J., Precursor lesions in pancreatic cancer: morphological and molecular pathology. Pathology 2011, 43, 183-200.
54. Shankar, S.; Ganapathy, S.; Hingorani, S. R.; Srivastava, R. K., EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer. Frontiers in Bioscience 2008, 13, 440-452.
55. Takada, M.; Nakamura, Y.; Koizumi, T.; Toyama, H.; Kamigaki, T.; Suzuki, Y.; Takeyama, Y.; Kuroda, Y., Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate. Pancreas 2002, 25, 45-48
56. Vu, H. A.; Beppu, Y.; Chi, H. T.; Sasaki, K.; Yamamoto, H.; Xinh, P. T.; Tan Hara, Y.; Watanabe, T.; Sato, Y.; Ohdomari, I., Green Tea Epigallocatechin G Exhibits Anticancer Effect in Human Pancreatic Carcinoma Cells via the Inhibiti Both Focal Adhesion Kinase and Insulin-Like Growth Factor-I Receptor. Journ Biomedicine and Biotechnology 2010, 2010, 1-8.
57. Qanungo, S; Das, M.; Haldar, S.; Basu, A., Epigallocatechin-3-gallate in mitochondrial membrane depolarization and caspase-dependent apoptosis in panc cancer cells Carcinogenesis 2005, 26, 958-967.
58. Lyn-Cook, B. D.; Rogers, T.; Yan, Y.; Blann, E. B.; Kadlubar, F. F.; Hammons, Chemopreventive Effects of Tea Extracts and Various Components on H Pancreatic and Prostate Tumor Cells in vitro. Nutrition and Cancer 1999, 35, 80-8
59. Li, Y.; Zhang, T.; Jiang, Y.; Lee, H.-F.; Schwartz, S. J.; Sun, D., (-)-Epigallocate 3-gallate Inhibits Hsp90 Function by Impairing Hsp90 Association with Cochape in Pancreatic Cancer Cell Line Mia Paca-2. Molecular Pharmaceutics 2009, 6, 1159.
60. Basu, A.; Haldar, S., Combinatorial effect of epigallocatechin-3-gallate and TRA pancreatic cancer cell death. International Journal of Oncology 2009, 34, 281-286
61. Tan, M.; Norwood, A.; May, M.; Tucci, M.; Benghuzzi, H., Effects of(-)epigallocatechin gallate and thymoquinone on proliferation of a PANC-1 cell li culture. Biomedical Sciences Instrumentation 2006, 42, 363-371.
62. Kürbitz, C.; Heise, D.; Redmer, T.; Goumas, F.; Arlt, A.; Lemke, J.; Rimbach Kalthoff, H.; Trauzold, A., Epicatechin gallate and catechin gallate are superi epigallocatechin gallate in growth suppression and anti-inflammatory activiti pancreatic tumor cells. Cancer Science 2011, 102, 728-734.
63. Zhang, L.; Pang, E.; Loo, R. R. O.; Rao, J.; Go, V.L. W.; Loo, J. A.; Lu, Q.Y., Concomitant inhibition of HSP90, its mitochondrial localized homologue TRAP HSP27 by green tea in pancreatic cancer HPAF-II cells. Proteomics 2011, 11, 4638-4647.
64. Ji, B. T.; Chow, W. H.; Hsing, A. W.; Mclaughlin, J. K.; Dai, Q.; Gao, Y. T.; Blo J.; FraumeniJr, J. F., Green tea consumption and the risk of pancreatic and colo cancers. International Journal of Cancer 1997, 70, 255-258.